AngioDynamics, Inc. (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (RFA), systems, irreversible electroporation (IRE), surgical resection systems and embolization products for treating benign and malignant tumors. The Company designs, develops, manufactures and markets a line of therapeutic and diagnostic devices that enable interventional physicians (interventional radiologists, vascular surgeons, surgical oncologists and others) to treat PVD, tumors, and other non-coronary diseases. The Company operates in three segments: Peripheral Vascular, Access and Oncology/Surgery. On January 12, 2009, the Company completed the acquisition of certain assets of FlowMedica, Inc.